Physician profile
Kaushal Patel
NPI 1285955955
$9,139.61
in general payments reported to CMS, 2019-2025
39 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,257 · 2020: $715 · 2021: $1,794 · 2022: $919 · 2023: $741 · 2024: $588 · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,454.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,075.52 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Accolade Sr |
| Abiomed | $1,934.35 | 2019-2025 | |
| Medtronic, INC. | $548.22 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $430.06 | 2022-2025 | Proclaim, Esprit, Perclose Proglide |
| Janssen Pharmaceuticals, INC | $429.75 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $313.70 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.44 | 2019-2024 | Lifevest |
| Medtronic Vascular, INC. | $233.62 | 2019-2020 | |
| Atricure, INC. | $206.40 | 2021 | |
| Cvrx, INC. | $157.99 | 2025 | Barostim Neo System |
| Tactile Systems Technology INC | $144.81 | 2019-2020 | |
| Heartflow, INC. | $138.56 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $135.63 | 2019-2024 | |
| Imperative Care, INC | $133.84 | 2025 | Symphony Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.98 | 2020-2025 | Jardiance |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $127.11 | 2022-2023 | Verquvo |
| Pfizer INC. | $91.47 | 2022-2025 | |
| Philips North America LLC | $80.01 | 2019 | |
| Angiodynamics, INC. | $72.11 | 2019-2020 | |
| Esperion Therapeutics, INC. | $61.97 | 2021 | |
| Intuitive Surgical, INC. | $55.20 | 2023 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $44.71 | 2022-2025 | Camzyos |
| Kiniksa Pharmaceuticals, Ltd. | $42.01 | 2023 | Arcalyst |
| Chiesi USA, INC. | $32.52 | 2019-2025 | Kengreal |
| Collegium Pharmaceutical, INC. | $24.56 | 2023 | Belbuca |
| Edwards Lifesciences Corporation | $23.68 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biotronik INC. | $22.78 | 2019 | |
| Impulse Dynamics (USA) INC. | $22.29 | 2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $21.62 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.31 | 2024 | |
| Baxter Healthcare | $17.74 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bracco Diagnostics INC. | $17.36 | 2023 | |
| Qorumpartners | $17.31 | 2022 | |
| Inspire Medical Systems, INC. | $16.96 | 2025 | Inspire |
| Novo Nordisk INC | $16.84 | 2024 | Ozempic, Rybelsus |
| Amgen INC. | $14.81 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $13.74 | 2024 | Arcalyst |
| Biocompatibles, INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaushal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.